1. Catalog
  2. GRBIOMEM2507 - CMLE - Navigating Biomarker Testing ...
GRBIOMEM2507 - CMLE - Navigating Biomarker Testing in Common Solid Tumors
Course Description

Navigating Biomarker Testing in Common Solid Tumors  

This is an elective module of the Biomarker Testing Navigation Certificate program.  This online, interactive module provides skills to prioritize tests, review biomarker results, and optimize workflows for cancers such as lung, breast, and colorectal. Participants will learn to align biomarkers with therapies, address challenges, and implement NCCN/ASCO guidelines.  

Course topics include:  

  • Common solid tumors  

  • Understanding predictive biomarkers in solid tumors  

  • Guidelines and best practices for biomarker testing in solid tumors  

  • Leveraging emerging technologies and trends to enhance biomarker testing triage for solid tumors 

Target Audience 

This activity has been designed to meet the educational needs of pathologists and laboratory professionals.  

Faculty/Authors

Rachel Starks, MD, Ph.D 
Clinical Assistant Professor, Pathology, University of South Dakota Sanford School of Medicine 
Sioux Falls, SD  

Physician's Competency: Patient Care, Medical Knowledge 

CMLE Credit: 1.5
Estimated Completion Time: 1.5 hour
Format: Online educational activity

Credit Designation Statement

ASCP designates this activity for a maximum of 1.5 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  

For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT. 

 

Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CMLE certificates will be provided online. 

Commercial Support 
This activity is supported by a sponsorship from AstraZeneca. 


Instructions

To claim CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 10/6/2025      
Review Date:
Expiration Date: 6/10/2028       




Course Objectives

Upon completion of this activity, you will be able to:

  • Specify the six most common solid tumors and their associated biomarker testing priorities.   

  • Differentiate between types of predictive biomarkers and explain their roles in guiding targeted therapy and immunotherapy decisions for solid tumors.   

  • Identify specific biomarker-directed therapies and their applications across common solid tumors.   

  • Integrate current guidelines and best practices into the prioritization and evaluation of biomarker testing for solid tumors.   

  • Assess emerging technologies for optimizing biomarker testing triage strategies.  


 

 

 
Summary
Availability:
On-Demand
Credit Offered:
1.5 CMLE Credits
Powered By